Trial Profile
Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs LC28 0126 (Primary)
- Indications Myocardial infarction
- Focus Pharmacodynamics
- Sponsors LG Chem; LG Life Sciences
- 18 May 2016 New trial record